Anti-C1S/ EDSPD2 functional antibody

Anti-C1S/ EDSPD2 functional antibody for cell culture, ELISA & in-vivo assay

Target products collectionGo to C1S/C1S products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-T76024-Ab-1/ GM-Tg-hg-T76024-Ab-2Anti-Human C1S monoclonal antibodyHuman
GM-Tg-rg-T76024-Ab-1/ GM-Tg-rg-T76024-Ab-2Anti-Rat C1S monoclonal antibodyRat
GM-Tg-mg-T76024-Ab-1/ GM-Tg-mg-T76024-Ab-2Anti-Mouse C1S monoclonal antibodyMouse
GM-Tg-cynog-T76024-Ab-1/ GM-Tg-cynog-T76024-Ab-2Anti-Cynomolgus/ Rhesus macaque C1S monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-T76024-Ab-1/ GM-Tg-felg-T76024-Ab-2Anti-Feline C1S monoclonal antibodyFeline
GM-Tg-cang-T76024-Ab-1/ GM-Tg-cang-T76024-Ab-2Anti-Canine C1S monoclonal antibodyCanine
GM-Tg-bovg-T76024-Ab-1/ GM-Tg-bovg-T76024-Ab-2Anti-Bovine C1S monoclonal antibodyBovine
GM-Tg-equg-T76024-Ab-1/ GM-Tg-equg-T76024-Ab-2Anti-Equine C1S monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-T76024-Ab-1/ GM-Tg-hg-T76024-Ab-2; GM-Tg-rg-T76024-Ab-1/ GM-Tg-rg-T76024-Ab-2;
GM-Tg-mg-T76024-Ab-1/ GM-Tg-mg-T76024-Ab-2; GM-Tg-cynog-T76024-Ab-1/ GM-Tg-cynog-T76024-Ab-2;
GM-Tg-felg-T76024-Ab-1/ GM-Tg-felg-T76024-Ab-2; GM-Tg-cang-T76024-Ab-1/ GM-Tg-cang-T76024-Ab-2;
GM-Tg-bovg-T76024-Ab-1/ GM-Tg-bovg-T76024-Ab-2; GM-Tg-equg-T76024-Ab-1/ GM-Tg-equg-T76024-Ab-2
Products NameAnti-C1S monoclonal antibody
Formatmab
Target NameC1S
Protein Sub-locationSecreted Protein/Potential Cytokines
Category of antibodyFACS/Biofunctional Antibody, Therapeutics Target antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-C1S benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    BiosimilarGMP-Bios-ab-537Pre-Made Sutimlimab biosimilar, Whole mAb, Anti-C1S Antibody: Anti-EDSPD2 therapeutic antibody
    Target AntigenGM-Tg-g-T76024-Ag-1Recombinant multi-species C1S/ EDSPD2 protein
    ORF Viral VectorpGMLP001461human C1S Lentivirus plasmid
    ORF Viral VectorvGMLP001461human C1S Lentivirus particle
    ORF Viral VectorpGMLPm004825mouse C1s1 Lentivirus plasmid
    ORF Viral VectorvGMLPm004825mouse C1s1 Lentivirus particle


    Target information

    Target IDGM-T76024
    Target NameC1S
    Gene ID716,317677,192262,714589,486714,101088676,767827,100060261
    Gene Symbol and SynonymsC1S,C1s2,C1sb,CC1s,EDSPD2,EG317677,Gm5077,r-gsp
    Uniprot AccessionP09871,Q6P6T1,Q0VCX1
    Uniprot Entry NameC1S_HUMAN,C1S_RAT,C1S_BOVIN
    Protein Sub-locationSecreted Protein/Potential Cytokines
    CategoryTherapeutics Target, INN Index
    DiseaseLung Cancer
    Gene EnsemblENSG00000182326
    Target ClassificationN/A

    The target: C1S, gene name: C1S, also named as EDSPD2. This gene encodes a serine protease, which is a major constituent of the human complement subcomponent C1. C1s associates with two other complement components C1r and C1q in order to yield the first component of the serum complement system. Defects in this gene are the cause of selective C1s deficiency. [provided by RefSeq, Mar 2009].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.